Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-15-000073

CEO bought 5,000 shares at an average $0.22 ($1,075)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2015-12-16 Purchase : show line 1 in the form +2,500 $0.23 $575 6,876,814 D
2015-12-17 Purchase : show line 2 in the form +2,500 $0.20 $500 6,879,314 D
Open-market purchases · 5,000 sh · avg $0.22 · $1,075
Loading xslF345X03/primary_doc.xml…